Investors in Opexa Therapeutics were crushed on Friday, with the stock tumbling more than 69% on enormous volume, settling at $1.05 a share, a level not seen since the company implemented a 1:8 reverse stock split in …
Getae
Opexa Therapeutics Inc. (NASDAQ:OPXA) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Wednesday. According to Zacks, “Opexa Therapeutics, Inc. …
Opexa might be left to wind down operations and leave the scraps to a company like Merck (MRK), who might be able to salvage at least some of the safety and tolerability data for future studies. At best, though, the value to …
QUALCOMM, Inc (QCOM) Stock: A Value Play Or A Value Trap? Alphabet Inc (GOOGL) Stock: Will The Shift In Search Trends Hurt Google? Don't Short Advanced Micro Devices Inc (AMD) Stock Right Now Why Advanced …
OPXA, the stock Opexa has now moved to a market capitalization of about $18 million. Considering that Tcelna has already reached phase IIb trials, I'm actually surprised to see such a cheap market capitalization although …
NASDAQ
Macrocure Ltd (MCUR): MCUR stock is up 19.39% today. Aptose Biosciences Inc (APTO): APTO stock is up 15.94% today. Opexa Therapeutics (OPXA): OPXA stock is up 12.58% today. Vericel Corporation (VCEL): …
Opexa Therapeutics, Inc. (NASDAQ: OPXA) announced that is offering to sell shares of its common stock and common stock purchase warrants in an underwritten public offering. All of the shares in the offering are to be …
Opexa Therapeutics, Inc. (NASDAQ:OPXA) has earned a consensus broker rating score of 2.33 (Buy) from the three analysts that provide coverage for the stock, Zacks Investment Research reports. Two analysts have …
BNS1mon
Stock market analysts and brokers have recently amended their target prices on shares of Opexa Therapeutics, Inc. (OPXA). The most recent analyst ratings issued by brokerages: 08/12/2016 – Opexa Therapeutics, Inc. …
Opexa Therapeutics Inc. (NASDAQ:OPXA) shares rose 5.1% during trading on Friday . The company traded as high as $4.73 and last traded at $4.50, with a volume of 176,003 shares traded. The stock had previously …